Microsoft Threat Intelligence has uncovered a ClickFix campaign in which compromised websites abuse browser cache storage to ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The average daily trading volume for Recursion Pharmaceuticals (RXRX) is 18,839,987. The opening price for Recursion Pharmaceuticals today was 4.18.
Sep. 21 Recursion Pharmaceuticals, Inc. Grants Tempus Ai, Inc. Non-Exclusive License for Rna Foundation Model CI Sep. 21 Tempus AI, Recursion Extend Data License, Amend Fee Structure MT ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals reported 5 insider transactions totaling $528,153.30. Activity split between 3 Tax Payments worth $351,830.92 and 2 Sales worth $176,322.38. Ben R Taylor and Najat Khan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results